pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
GLP-1 receptor · news · pharmadog
← back to GLP-1 receptor
News · GLP-1 receptor
341
stories
Aug 12, 26
Replimune finally wins approval, Q2 earnings wrap up, psychedelics stay in spotlight
biospace
Aug 12, 26
Opinion: Climate change is making people with chronic illness even sicker
stat
Aug 11, 26
Opinion: Trump says his executive order should restore trust in vaccines. It does the exact opposite
stat
Aug 11, 26
Scholar Rock rejigs approval filing after FDA flags violations at Novo plant
biospace
Aug 11, 26
Opinion: The new geography of abortion care
stat
Aug 11, 26
Opinion: Burdensome Medicare GLP-1 program may keep patients from accessing $50 per month weight loss drugs
stat
Aug 11, 26
STAT+: Nurses seek a seat at the table as they fight expanding clinical AI
stat
Aug 10, 26
AstraZeneca partners with CSPC to build Chinese biologics manufacturing plant
biospace
Aug 7, 26
A third clinic settles with DOJ over trans care
stat
Aug 7, 26
Latigo IPO raises nearly $350M for pain drug development
biopharma dive
Aug 7, 26
Novo Nordisk’s CFO on the oral Wegovy rollout and beyond
fiercebiotech
Aug 5, 26
Lilly confident in slow and steady Foundayo launch, as ex-US sales shine
biospace
Aug 5, 26
Lilly, FDA retatrutide biologic dispute comes to a head as submission nears
biospace
Aug 5, 26
Lilly climbs, Novo falls as obesity drug battle intensifies
biopharma dive
Aug 5, 26
Lilly’s $23B Q2 soars over expectations but Foundayo lags Novo’s rival oral GLP-1
biospace
Aug 5, 26
STAT+: Moderna launches early trial of Ebola mRNA vaccine
stat
Aug 5, 26
Amgen’s MariTide stands alone after obesity cull while analysts seek more M&A
biospace
Aug 5, 26
Novo CEO sees innovation as a matter of survival amid pipeline setbacks
biospace
Aug 5, 26
Lilly once again beats expectations as tirzepatide accounts for 64% of revenue
endpoints
Aug 5, 26
‘It’s been a roller coaster’: Novo Nordisk’s CFO reflects on ‘pressure’ to drive growth
fiercebiotech
Aug 5, 26
Novo CEO accepts ‘couple of setbacks’ in R&D as CagriSema posts more mixed data
fiercebiotech
Aug 4, 26
Novo dips 6% on Wegovy pill stumble despite Q2 earnings beat
biospace
Aug 4, 26
Pfizer cuts $2.5B more across R&D, manufacturing in ongoing restructure
biospace
Aug 4, 26
Amgen drops early-stage obesity drug, upping pressure on MariTide
fiercebiotech
Aug 4, 26
Pfizer axes ex-Metsera obesity asset and GIPR prospect in quarterly clearout
fiercebiotech
Aug 3, 26
Biologics push CMOs/CDMOs to expand sterile fill-finish and prefilled syringe capacity
biospace
Jul 31, 26
Lilly and Resilience invest $750M in diabetes and obesity drug device supply
biospace
Jul 31, 26
Resilience and Lilly invest $750M to boost Cincinnati drug production
biopharma dive
Jul 31, 26
Novo's IL-6 inhibitor fails in cardiovascular Phase 3, plunging shares more than 9%
biospace
Jul 31, 26
STAT+: Pharmalittle: We’re reading about a Novo setback, support for Replimune’s melanoma drug, and more
stat
← prev
page 6 of 12
next →
